Dehydroepiandrosterone (DHEA), Six Specimens
Use
The Dehydroepiandrosterone (DHEA) test measures the level of DHEA hormone which can be used to assess adrenal gland function. This test consists of a series of specimens collected at multiple time points, typically before and after administering a drug, to observe changes in DHEA levels. It is commonly used to evaluate adrenal function, diagnose conditions such as adrenal insufficiency or hyperplasia, and monitor the treatment of such disorders.
Special Instructions
This panel requires multiple specimens taken at different intervals and is used in cases where the patient is administered a drug or treatment post the initial specimen collection. Ensure a clinician is contacted to confirm the appropriateness of the series order and instructions are followed from the Endocrine Appendix for multiple specimen collection.
Limitations
The test may be affected by various factors including the time of day and the patient's physiological state since DHEA levels naturally fluctuate. Proper specimen collection timing is critical to obtain accurate and meaningful results. Results should be interpreted in the context of other clinical findings and tests.
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 46963-5
- 2193-1
- 12590-6
- 12591-4
- 12592-2
- 12593-0
- 12594-8
Result Turnaround Time
4-6 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Refer to the Endocrine Appendix for instructions on multiple specimen collection. It's important to collect the initial specimen, administer the designated treatment, and then collect subsequent specimens at designated time points.
